Low-dose erythropoietin treatment is not associated with clinical benefits in severely anaemic Jehovah's Witnesses: a plea for a change

Low-dose erythropoietin treatment is not associated with clinical benefits in severely anaemic Jehovah's Witnesses: a plea for a change

Jehovah's Witnesses who refuse blood transfusion have high mortality. Erythropoietin (EPO) has been used as an alternative to blood transfusion. The optimal dosing of EPO in anaemic Jehovah's Witnesses is unknown. The aim of our study was to evaluate the clinical benefits of treatment with...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Blood transfusion = Trasfusione del sangue 2018-01, Vol.16 (1), p.53-62
Hauptverfasser: Beliaev, Andrei M, Allen, Sara J, Milsom, Paget, Nand, Parma, Smith, Warren M, Bergin, Colleen J
Format: Artikel
Sprache:eng
Schlagworte:
Adult
Aged
Anemia - blood
Anemia - drug therapy
Anemia - mortality
Databases, Factual
Disease-Free Survival
Erythropoietin - administration & dosage
Erythropoietin - adverse effects
Female
Humans
Jehovah's Witnesses
Male
Middle Aged
Original
Retrospective Studies
Survival Rate
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Jehovah's Witnesses who refuse blood transfusion have high mortality. Erythropoietin (EPO) has been used as an alternative to blood transfusion. The optimal dosing of EPO in anaemic Jehovah's Witnesses is unknown. The aim of our study was to evaluate the clinical benefits of treatment with a low dose (
ISSN:1723-2007
2385-2070
DOI:10.2450/2016.0085-16